Search
for
Sort by
Research 271–300 of 1000+
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Immune cell regulation of the hair cycle
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- New drugs under investigation for the treatment of alopecias
- Treating Alopecia Areata: Current Practices Versus New Directions
- Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Treatment of severe alopecia areata with baricitinib
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Safety concerns when using novel medications to treat alopecia
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Alopecia Areata: An Update on Treatment Options for Children
- Current Treatments for Alopecia Areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Novedades terapéuticas en tricología
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- The Changing Landscape of Alopecia Areata: The Translational Landscape